GB0406917D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0406917D0
GB0406917D0 GBGB0406917.5A GB0406917A GB0406917D0 GB 0406917 D0 GB0406917 D0 GB 0406917D0 GB 0406917 A GB0406917 A GB 0406917A GB 0406917 D0 GB0406917 D0 GB 0406917D0
Authority
GB
United Kingdom
Prior art keywords
acid
ala
less
salts
photochemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0406917.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Priority to GBGB0406917.5A priority Critical patent/GB0406917D0/en
Publication of GB0406917D0 publication Critical patent/GB0406917D0/en
Priority to CA2561050A priority patent/CA2561050C/en
Priority to ES10011759.7T priority patent/ES2639021T3/es
Priority to RU2006135487/04A priority patent/RU2392266C2/ru
Priority to AT05732530T priority patent/ATE514672T1/de
Priority to AU2005225616A priority patent/AU2005225616B2/en
Priority to EP05732530A priority patent/EP1727786B1/en
Priority to PL05732530T priority patent/PL1727786T3/pl
Priority to DK05732530.0T priority patent/DK1727786T3/da
Priority to ES05732530T priority patent/ES2367789T3/es
Priority to SI200531338T priority patent/SI1727786T1/sl
Priority to CN2005800098456A priority patent/CN1938264B/zh
Priority to PCT/GB2005/001236 priority patent/WO2005092838A1/en
Priority to PT05732530T priority patent/PT1727786E/pt
Priority to US10/594,361 priority patent/US7888526B2/en
Priority to EP10011759.7A priority patent/EP2308830B1/en
Priority to JP2007504487A priority patent/JP5164565B2/ja
Priority to US12/916,326 priority patent/US8692014B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0406917.5A 2004-03-26 2004-03-26 Compounds Ceased GB0406917D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB0406917.5A GB0406917D0 (en) 2004-03-26 2004-03-26 Compounds
JP2007504487A JP5164565B2 (ja) 2004-03-26 2005-03-29 ５−アミノレブリン酸又はその誘導体の酸付加塩
DK05732530.0T DK1727786T3 (da) 2004-03-26 2005-03-29 Syreadditionssalte af 5-aminolevulinsyre eller dens derivater
SI200531338T SI1727786T1 (sl) 2004-03-26 2005-03-29 Kisle dodatne soli 5-aminolevulinske kisline ali njenih derivatov
RU2006135487/04A RU2392266C2 (ru) 2004-03-26 2005-03-29 Соли присоединения кислоты 5-аминолевулиновой кислоты или ее производных
AT05732530T ATE514672T1 (de) 2004-03-26 2005-03-29 Säureadditionssalze von 5-aminolevulinsäure oder derivaten davon
AU2005225616A AU2005225616B2 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
EP05732530A EP1727786B1 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
PL05732530T PL1727786T3 (pl) 2004-03-26 2005-03-29 Kwasowe addycyjne sole kwasu 5-aminolewulinowego lub jego pochodnych
CA2561050A CA2561050C (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
ES05732530T ES2367789T3 (es) 2004-03-26 2005-03-29 Sales de adición de ácido del ácido 5-aminolevulínico o de sus derivados.
ES10011759.7T ES2639021T3 (es) 2004-03-26 2005-03-29 Sales de adición de ácido del ácido 5-aminolevulínico o sus derivados
CN2005800098456A CN1938264B (zh) 2004-03-26 2005-03-29 5-氨基乙酰丙酸或其衍生物的酸加成盐
PCT/GB2005/001236 WO2005092838A1 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
PT05732530T PT1727786E (pt) 2004-03-26 2005-03-29 Sais de adição ácida de ácido 5-aminolevulínico ou seus derivados
US10/594,361 US7888526B2 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
EP10011759.7A EP2308830B1 (en) 2004-03-26 2005-03-29 Acid addition salts of 5-aminolevulinic acid or its derivatives
US12/916,326 US8692014B2 (en) 2004-03-26 2010-10-29 Acid addition salts of 5-aminolevulinic acid or its derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0406917.5A GB0406917D0 (en) 2004-03-26 2004-03-26 Compounds

Publications (1)

Publication Number Publication Date
GB0406917D0 true GB0406917D0 (en) 2004-04-28

Family

ID=32188818

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0406917.5A Ceased GB0406917D0 (en) 2004-03-26 2004-03-26 Compounds

Country Status (15)

Country Link
US (2) US7888526B2 (https=)
EP (2) EP1727786B1 (https=)
JP (1) JP5164565B2 (https=)
CN (1) CN1938264B (https=)
AT (1) ATE514672T1 (https=)
AU (1) AU2005225616B2 (https=)
CA (1) CA2561050C (https=)
DK (1) DK1727786T3 (https=)
ES (2) ES2367789T3 (https=)
GB (1) GB0406917D0 (https=)
PL (1) PL1727786T3 (https=)
PT (1) PT1727786E (https=)
RU (1) RU2392266C2 (https=)
SI (1) SI1727786T1 (https=)
WO (1) WO2005092838A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653653B2 (en) 2016-01-26 2020-05-19 Ming Zhao Salts of 5-aminolevulinic acid and derivatives

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005025614D1 (de) * 2004-03-30 2011-02-10 Cosmo Oil Co Ltd 5-aminolevulinsäure-phosphatsalz, verfahren zu dessen herstellung und dessen verwendung
JP4719483B2 (ja) * 2004-03-30 2011-07-06 コスモ石油株式会社 ５−アミノレブリン酸スルホン酸塩の製造方法
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP4934292B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途
JP4934293B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 植物活力剤組成物
US20070225518A1 (en) * 2006-03-22 2007-09-27 Zvi Malik 5-Aminolevulinic acid salts and their use
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
JP4989153B2 (ja) 2006-08-15 2012-08-01 コスモ石油株式会社 ５−アミノレブリン酸リン酸塩の新規結晶及びその製造方法
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
CN103626639B (zh) * 2008-10-30 2016-12-07 阿彻丹尼尔斯米德兰德公司 用金属催化剂还原hmf醚
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2394642A1 (en) 2010-06-10 2011-12-14 Universite De Geneve 5-ALA ester formulations and use thereof
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
CA2880422C (en) 2012-08-03 2021-02-09 Photocure Asa Derivatives of 5-aminolevulinic acid
WO2014026077A1 (en) 2012-08-10 2014-02-13 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
JP6595484B2 (ja) 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 光損傷皮膚のパルス光力学的処置
EP3095464A1 (en) 2015-05-19 2016-11-23 Universite De Geneve 5-ala derivatives and use thereof
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522311D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
BR112018011965A2 (pt) 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
RU2611441C2 (ru) * 2016-04-28 2017-02-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Способ получения гидрохлорида метилового эфира 5-аминолевулиновой кислоты
KR20190112096A (ko) 2017-02-06 2019-10-02 쓰리스킨 에이에스 자외선 차단제 조성물
CN108088838A (zh) * 2017-12-13 2018-05-29 西南大学 双[2,4,6-三氯苯基]草酸酯在测定链格孢霉毒素中的应用及方法
CN108440319B (zh) * 2018-04-26 2021-05-18 爱斯特（成都）生物制药股份有限公司 一种制备盐酸氨基乙酰丙酸的方法
EP3868372A1 (en) 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
CN115671059B (zh) * 2022-11-17 2024-06-11 兆科药业（合肥）有限公司 一种盐酸氨酮戊酸冻干制剂及制备方法
CN116162038A (zh) * 2023-01-06 2023-05-26 河南省精细化工研究院有限公司 一种5-氨基乙酰丙酸盐酸盐的环保型生产工艺
CN120957714A (zh) 2023-03-07 2025-11-14 光治疗Asa公司 膀胱癌疗法
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JP2767318B2 (ja) * 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
EP0483714B1 (en) * 1990-10-29 1995-05-03 Japan Tobacco Inc. A method of preparing an acid additional salt of delta-aminolevulinic acid
US5284973A (en) * 1990-10-29 1994-02-08 Japan Tobacco Inc. Method of preparing an acid additional salt of delta-aminolevulinic acid
JP2613136B2 (ja) * 1991-05-14 1997-05-21 株式会社コスモ総合研究所 植物成長促進剤
JP2997979B2 (ja) 1993-01-20 2000-01-11 株式会社コスモ総合研究所 ５−アミノレブリン酸の製造方法
JP2887554B2 (ja) * 1993-08-19 1999-04-26 株式会社コスモ総合研究所 植物の蓚酸含量低減剤
US5489572A (en) 1993-08-19 1996-02-06 Cosmo Research Institue Methods for reducing nitrate nitrogen and oxalic acids contents nin plants
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JPH07238063A (ja) 1994-02-25 1995-09-12 Cosmo Sogo Kenkyusho:Kk ５−アミノレブリン酸の回収精製法
JP2896963B2 (ja) 1994-11-28 1999-05-31 株式会社コスモ総合研究所 植物の耐塩性向上剤
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
ATE202076T1 (de) 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
US6992107B1 (en) * 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
DE69826487T2 (de) 1997-07-30 2005-12-01 Wyeth Trizyclische vasopressin-agonisten
US5907058A (en) * 1998-07-29 1999-05-25 Midwest Research Institute Synthesis of an acid addition salt of delta-aminolevulinic acid from 5-bromo levulinic acid esters
GB0018527D0 (en) 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
DE602005025614D1 (de) * 2004-03-30 2011-02-10 Cosmo Oil Co Ltd 5-aminolevulinsäure-phosphatsalz, verfahren zu dessen herstellung und dessen verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653653B2 (en) 2016-01-26 2020-05-19 Ming Zhao Salts of 5-aminolevulinic acid and derivatives

Also Published As

Publication number Publication date
AU2005225616B2 (en) 2011-08-18
CA2561050A1 (en) 2005-10-06
DK1727786T3 (da) 2011-08-29
CN1938264A (zh) 2007-03-28
JP2007530523A (ja) 2007-11-01
SI1727786T1 (sl) 2011-09-30
US20080064752A1 (en) 2008-03-13
ES2639021T3 (es) 2017-10-25
AU2005225616A1 (en) 2005-10-06
CN1938264B (zh) 2012-05-23
US20110125012A1 (en) 2011-05-26
EP1727786B1 (en) 2011-06-29
RU2392266C2 (ru) 2010-06-20
ATE514672T1 (de) 2011-07-15
US7888526B2 (en) 2011-02-15
CA2561050C (en) 2012-05-08
PT1727786E (pt) 2011-07-08
EP2308830B1 (en) 2017-06-14
PL1727786T3 (pl) 2011-11-30
ES2367789T3 (es) 2011-11-08
WO2005092838A1 (en) 2005-10-06
EP2308830A1 (en) 2011-04-13
EP1727786A1 (en) 2006-12-06
US8692014B2 (en) 2014-04-08
RU2006135487A (ru) 2008-05-10
JP5164565B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
GB0406917D0 (en) Compounds
EP1780197A4 (en) 5-SUBSTITUTED 2-PHENYLAMINOBENZAMID AS MEK INHIBITOR
TNSN07148A1 (en) (biphenyl) carboxylic acids and derivatives thereof
GB0018528D0 (en) Compounds
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
WO2005099680A3 (en) Use of treprostinil to treat neuropathic diabetic foot ulcers
DK1814534T3 (da) Derivater af 5-aminolevulinsyre til behandling af acne
TW200736252A (en) Novel heteroaryl substituted benzothiazoles
ECSP088587A (es) Compuestos de piperidina 3,5-sustituida como inhibidores de renina
MX2010008097A (es) Acido (-) 2-[1-(7-metil-2-(morfolin-4-il)-4-oxo-4h-pirido [1,2-a] pirimidin-9-il) etilamino]benzoico enantiomericamente puro, su uso en terapia medica, y una composicion farmaceutica que lo comprende - 026.
PL377478A1 (pl) Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne
EP1784388B8 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
EA200802172A1 (ru) Замещенные бифенилкарбоновые кислоты и их производные
WO2007001940A3 (en) Imaging agents
WO2003006443A3 (de) 2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie
DK1853248T3 (da) Anvendelse af salte, additionsforbindelser og kompleksforbindelser af quanidinoeddikesyre
WO2007119004A3 (fr) Methode de diagnostic in vitro ou ex vivo de desordres psychiatriques et/ou de dysbioses intestinales
WO2006103274A8 (fr) Inhibiteurs d'age
WO2007006534A3 (en) Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
DE60302676D1 (de) Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente
NO20015666L (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
BR0316751A (pt) Análogos de gabapentina para fibromialgia e outros distúrbios relacionados
EA200401432A1 (ru) Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков
ATE360614T1 (de) Verbindung für die behandlung von atherosclerotischen und thrombotischen erkrankungen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)